Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise
NCT ID: NCT07321587
Last Updated: 2026-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2026-01-26
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Managing Pain and Cognitions in Older Adults With Early Cognitive Decline and Chronic Pain
NCT05373745
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
NCT01561820
Cognitive Control to Boost Physical Activity Adherence
NCT06338774
Movement Intervention for Memory Enhancement
NCT03475316
Walking on Cognitive Function in Individuals With Mild Cognitive Impairment: A Pilot Project
NCT04498195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention, then Control
Week 1 (Pre-Intervention): Participants will wear the Fitbit smartwatch during waking hours. Data collected during this week will serve as baseline and for troubleshooting technical issues.
Weeks 2-4 (Intervention): Participants will receive the ACTIVE intervention (Activity tracking, Care partner co-participation, Text reminders, Instructional education, Virtual physical therapy and Exercise).
Week 5 (Crossover/Washout): Participants will switch arms (intervention to control).
Weeks 6-8 (Control): Participants will continue in the control arm (Fitbit use only).
ACTIVE Intervention
The ACTIVE Intervention comprises the following components:
* Fitbit Smartwatch-Based Activity Tracking
* Care Partner Co-Participation
* Motivational Text Messaging
* Instructional Education Videos
* Virtual Physical Therapy
* Exercise (Walking Exercise)
Control, then Intervention
Week 1 (Pre-Control): Participants will wear the Fitbit smartwatch during waking hours. Data collected during this week will serve as baseline and for troubleshooting technical issues.
Weeks 2-4 (Control): Participants will continue in the control arm (Fitbit use only).
Week 5 (Crossover/Washout): Participants will switch arms (control to intervention).
Weeks 6-8 (Intervention): Participants will the ACTIVE intervention (Activity tracking, Care partner co-participation, Text reminders, Instructional education, Virtual physical therapy and Exercise).
ACTIVE Intervention
The ACTIVE Intervention comprises the following components:
* Fitbit Smartwatch-Based Activity Tracking
* Care Partner Co-Participation
* Motivational Text Messaging
* Instructional Education Videos
* Virtual Physical Therapy
* Exercise (Walking Exercise)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACTIVE Intervention
The ACTIVE Intervention comprises the following components:
* Fitbit Smartwatch-Based Activity Tracking
* Care Partner Co-Participation
* Motivational Text Messaging
* Instructional Education Videos
* Virtual Physical Therapy
* Exercise (Walking Exercise)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥65 years.
* With or without mild dementia.
* Willing to consent to participate in the study or have an LAR that is willing to consent for their participation in the study
* Willing to wear a Fitbit smartwatch, receive text messages, watch intervention-related videos, participate in physical therapy, and walking exercise.
* No contraindications to engaging in physical activity.
Care Partners:
* Age ≥18 years.
* Met criteria for survey participation.
* Person being cared for is recruited in the study.
* Willing to consent to participation
* Willing to wear a Fitbit smartwatch, receive text messages, watch intervention-related videos, participate in physical therapy, and walking exercise.
* No contraindications to engaging in physical activity.
Exclusion Criteria
* Severe cardiac, neurologic, or musculoskeletal condition (including but not limited to recent or untreated fracture in any part of the body)
* limiting participation in daily walking or Fitbit smartwatch use.
* Moderate to severe dementia (using the clinical dementia rating scale of 2 or higher
* Inability to operate or manage a Fitbit smartwatch device (even with care partner support).
* No phone or phone not capable of receiving text messages or watching videos.
* No internet for watching videos
Care Partners:
* Severe cardiac, neurologic, or musculoskeletal condition limiting participation in daily walking or Fitbit smartwatch use.
* Pregnant care partners
* Any level of dementia or cognitive impairment among care partners
* Inability to operate or manage a Fitbit smartwatch device.
* Inability to co-participate in intervention tasks with older adult
* No phone or phone not capable of receiving text messages or watching videos.
* No internet for watching videos
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dowin Boatright, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25-01158
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.